Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification of molecular targets in vulvar cancers.

Gynecologic oncology - 1 Aug 2017

Palisoul Marguerite L, Mullen Mary M, Feldman Rebecca, Thaker Premal H

Abstract excerpt

OBJECTIVES: To identify molecular alterations that contribute to vulvar cancer pathogenesis with the intent of identifying molecular targets for treatment. METHODS: After retrospective analysis of a database of molecularly-profiled gynecologic cancer patients, 149 vulvar cancer patients were included and tested centrally at a CLIA laboratory (Caris Life Sciences, Phoenix, AZ). Tests included one or more of the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Vulvar Neoplasms
Share to Ataxia Telangiectasia Mutated Proteins
Share to Chromogranins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to F-Box Proteins

Share to F-Box-WD Repeat-Containing Protein 7

Share to GTP-Binding Protein alpha Subunits, Gs

Share to Receptor, ErbB-4

Share to Receptor, Fibroblast Growth Factor, Type 2

Source

Identifiers

PMID: 28536037
DOI: 10.1016/j.ygyno.2017.05.011

Genes

BRAF
BRCA2
GNAS
AKT1
ATM
ERBB4
FGFR2
HRAS
KRAS
NRAS
PTEN

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification of molecular targets in vulvar cancers.PMID 28536037Read ↗

Somatic mutation profiling of vulvar cancer: Exploring therapeutic targets.Semantic proximity Read ↗

A review of reviews of the prevalence of molecular biomarkers in vulvar cancer and their implications for prognosis refinement and treatment strategies.Semantic proximity Read ↗

Molecular events in the pathogenesis of vulvar squamous cell carcinoma.Semantic proximity Read ↗

Vulvar Squamous Cell Carcinoma: Comprehensive Genomic Profiling of HPV+ Versus HPV– Forms Reveals Distinct Sets of Potentially Actionable Molecular TargetsSemantic proximity Read ↗

The Genomic Landscape of Vulvar Squamous Cell Carcinoma.Semantic proximity Read ↗

CDKN2A(p16) and HRAS are frequently mutated in vulvar squamous cell carcinoma.Semantic proximity Read ↗

Genomic Characterization of Vulvar (Pre)cancers Identifies Distinct Molecular Subtypes with Prognostic Significance.Semantic proximity Read ↗

Molecular Guided Treatments in Gynecologic Oncology: Analysis of a Real-World Precision Cancer Medicine Platform.Semantic proximity Read ↗

Mutational signatures and chromosome alteration profiles of squamous cell carcinomas of the vulva.Semantic proximity Read ↗

The forgotten woman's cancer: vulvar squamous cell carcinoma (VSCC) and a targeted approach to therapy.Semantic proximity Read ↗

Molecular Landscape of Vulvar Squamous Cell Carcinoma.Semantic proximity Read ↗

Genomic characterization of vulvar squamous cell carcinoma reveals differential gene expression based on clinical outcome.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.